Merit Organics Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Merit Organics Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $828.0K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Merit Organics Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $828.0K Trade | TransData Nexus

Merit Organics Limited

Indian Pharmaceutical Exporter · Advanced Antibiotics Specialist · $828.0K Total Trade · DGFT Verified

Merit Organics Limited is an Indian pharmaceutical exporter with a total trade value of $828.0K across 2 products in 2 therapeutic categories. Based on 26 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Flucloxacillin ($755.8K), Primaquine ($72.2K), .

Merit Organics Limited — Export Portfolio & Destination Treemap

Merit Organics Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Merit Organics Limited? — Company Overview & Market Position

Merit Organics Limited is a pharmaceutical company established on May 22, 1992, in Mumbai, Maharashtra, India. Operating as a public limited company, it is registered under the Corporate Identification Number (CIN) U51100MH1992PLC066904. The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. As of the latest available data, Merit Organics has an authorized capital of ₹7.25 crore and a paid-up capital of ₹6.88 crore. The company employs approximately 10 professionals.

The company's registered office is located at Unit 509, Western Edge-1, Off. W.E. Highway, Borivali East, CCI Compound, Mumbai, Maharashtra, 400066. Merit Organics is unlisted and operates in the manufacturing sector, focusing on chemicals and chemical products, particularly pharmaceuticals and medicinal chemicals.

What Does Merit Organics Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Flucloxacillin$755.8K 2

Product Portfolio — Top 2 by Export Value

Merit Organics Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Flucloxacillin	Advanced Antibiotics	$755.8K	21	1.9%	8
2	Primaquine	Antimalarial & Antiparasitic	$72.2K	5	4.3%	4

Merit Organics Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $828.0K. The top category is Advanced Antibiotics (91.3% of portfolio), followed by Antimalarial & Antiparasitic (8.7%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Merit Organics Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Merit Organics Limited operates manufacturing facilities in Mumbai, Maharashtra, India. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding the capacities and specializations of these facilities are not publicly disclosed. The company's commitment to quality is evident in its motto: "Quality is just not a test but an in-built property of the products."

3Key Leadership

The leadership team at Merit Organics Limited includes:

Purshottam Atmaram Kejriwal: Managing Director, appointed on May 22, 1992.

Vibhu Purushottam Kejriwal: Director, appointed on March 31, 2023.

Jyoti Devi Kejriwal: Whole-Time Director, appointed on February 11, 2019.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Merit Organics Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Merit Organics Limited's export portfolio is concentrated in two therapeutic categories: Advanced Antibiotics (91.3%) and Antimalarial & Antiparasitic (8.7%). The company's top two exported products are Flucloxacillin, with a total export value of $756K (Rank #8, 1.9% market share), and Primaquine, with a total export value of $72K (Rank #4, 4.3% market share). These figures indicate a strong presence in the global market for these specific pharmaceutical formulations.

2Emerging Markets

Merit Organics Limited's export data does not specify its presence in emerging markets such as Africa, Latin America, or Southeast Asia. The company's focus on Advanced Antibiotics and Antimalarial & Antiparasitic products suggests potential opportunities in regions with high disease burdens, where such medications are in demand. However, without explicit data on market penetration or WHO prequalification status, a detailed assessment of its position in these markets cannot be made.

3Geographic Strategy

Merit Organics Limited's export strategy appears to be highly concentrated, with its top five products accounting for 100% of its export value. This indicates a lack of diversification in its product portfolio, which could pose risks if market dynamics shift or if there are regulatory changes affecting these specific products. A more diversified product range could mitigate such risks and open avenues in different therapeutic areas.

Merit Organics Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Merit Organics Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history is not publicly available. Given the company's focus on finished pharmaceutical formulations, obtaining FDA approvals would be crucial for accessing the U.S. market. The absence of publicly available data suggests that the company may not currently have FDA-approved products or facilities.

2WHO & EU GMP

There is no publicly available information confirming whether Merit Organics Limited holds WHO prequalification or EU Good Manufacturing Practice (GMP) certificates. These certifications are essential for accessing international markets, particularly in regions where regulatory standards are stringent. The lack of such certifications could limit the company's ability to expand its global footprint.

3CDSCO & Indian Regulatory

Merit Organics Limited is registered with the Central Drugs Standard Control Organisation (CDSCO) in India, as indicated by its Corporate Identification Number (CIN) U51100MH1992PLC066904. Specific details regarding its manufacturing licenses, approvals from state drug controllers, or export No Objection Certificates (NOCs) are not publicly disclosed. These regulatory approvals are vital for ensuring compliance with Indian pharmaceutical manufacturing standards and for facilitating exports.

Merit Organics Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical export market, Merit Organics Limited faces competition from various companies specializing in antibiotic and antimalarial formulations. While specific competitors are not identified in the available data, the company's focus on Advanced Antibiotics and Antimalarial & Antiparasitic products places it in direct competition with other manufacturers in these therapeutic areas. The company's market share in these segments is relatively modest, indicating a competitive landscape with numerous players.

2Key Differentiators

Merit Organics Limited's commitment to quality is encapsulated in its motto: "Quality is just not a test but an in-built property of the products." This emphasis on quality could serve as a competitive advantage, particularly in markets where product reliability and efficacy are paramount. However, the company's lack of diversification in its product portfolio and the absence of certain international certifications may limit its ability to fully leverage this strength.

3Strategic Position

Merit Organics Limited's current strategic direction appears to be focused on the manufacturing and export of finished pharmaceutical formulations, particularly in the antibiotic and antimalarial segments. The company's unlisted status and limited public financial disclosures suggest a conservative approach to expansion and investment. Future strategic directions could include diversifying its product portfolio, obtaining international certifications, and exploring new markets to enhance growth and mitigate risks associated with its current concentration.

Buyer Due Diligence Brief — Evaluating Merit Organics Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Merit Organics Limited's export data indicates a total export value of $828K USD across 26 shipments, with a portfolio concentrated entirely on its top five products. This suggests a consistent supply chain and product demand. However, the lack of diversification in its product range and the absence of certain international certifications may impact the company's reliability and competitiveness in the global market.

2Certifications to Verify

Importers should verify the following certifications before engaging with Merit Organics Limited:

FDA Facility Registration: To confirm compliance with U.S. manufacturing standards. Verification can be done through the FDA's official website.

WHO Prequalification: To ensure adherence to international quality standards. Verification can be done through the WHO's official website.

EU GMP Certificate: To confirm compliance with European manufacturing standards. Verification can be done through the European Medicines Agency's official website.

Frequently Asked Questions — Merit Organics Limited

How many pharmaceutical products does Merit Organics Limited export from India?

Merit Organics Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Flucloxacillin ($755.8K), Primaquine ($72.2K). Total export value is $828.0K.

What is Merit Organics Limited's total pharmaceutical export value?

Merit Organics Limited's total pharmaceutical export value is $828.0K, based on 26 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Merit Organics Limited cover?

Merit Organics Limited exports across 2 therapeutic categories. The largest are Advanced Antibiotics (91.3%, 1 products), Antimalarial & Antiparasitic (8.7%, 1 products).

Get Full Merit Organics Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.